#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer metastatic Anal cancer Familial dilated cardiomyopathy Rectal cancer Rosai-Dorfman syndrome Macular telangiectasia Penile squamous cell carcinoma Myelodysplastic syndrome with excess blasts Necrotising myositis Sexually transmitted disease Hypereosinophilic syndrome Erdheim-Chester disease Plasma cell myeloma refractory ABO haemolytic disease of newborn Gastric cancer More trials…

    Learn about Rare Diseases

    Pleomorphic leiomyosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia – Treatment Basal cell naevus syndrome – Basic Information Hereditary hypophosphataemic rickets Methylmalonic acidaemia – Diagnostics Mucous membrane pemphigoid – Basic Information Osteosarcoma recurrent – Diagnostics Gaucher’s disease type I – Treatment Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Progressive supranuclear palsy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amcenestrant Tabelecleucel Furosemide Ph. Eur. Leniolisib Phosphate Chlorphenamine Zilucoplan Sodium Sodium Chloride Rozanolixizumab Arachis Hypogaea (762) Promethazine Hydrochloride Sabestomig Tipiracil Hydrochloride Ribociclib Ertapenem Nusinersen Biotin Pentoxifylline Resmetirom Oms906 Urea More therapies…

    Learn about Your Condition

    Endometrial cancer stage III Rosai-Dorfman syndrome Malignant peritoneal neoplasm Arthroscopy Atrophic vulvovaginitis Prinzmetal angina Herpes zoster Lung adenocarcinoma stage IV Vasospasm Inguinal hernia Hypochondroplasia Right ventricular dysfunction Endocarditis Eosinophilic oesophagitis Delirium More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Regionale San Carlo

Azienda Ospedaliera Regionale San Carlo

Via Potito Petrone, Potenza, 85100, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • R2R01
    • Sodium Chloride
    Germany Italy

  • A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Odronextamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia France Germany Italy +2

  • Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Dapagliflozin
    • Empagliflozin
    Italy

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study on Regorafenib for Patients with Advanced RAS-Mutant Colorectal Cancer Using Regorafenib and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Irinotecan Hydrochloride Trihydrate
    • Aflibercept
    Italy

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Elacestrant
    • Exemestane
    Austria Belgium Czechia Denmark Finland France +9

  • Study on Aspirin and Metformin for Patients with Locally Advanced Rectal Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer stage II
    • Colorectal cancer stage III
    Investigated Drugs:
    • Carbasalate Calcium
    • Capecitabine
    • Metformin Embonate
    Italy

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial flutter
    • Chronic coronary syndrome
    • Acute coronary syndrome
    Investigated Drugs:
    • Dabigatran
    • Apixaban
    • Edoxaban
    Belgium France Germany Italy The Netherlands Poland +1

  • Study of Valproic Acid, Panitumumab, and Irinotecan for Patients with Metastatic Colorectal Cancer with RAS/BRAF Wild-Type

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Valproic Acid
    • Panitumumab
    • Irinotecan Hydrochloride Trihydrate
    Italy
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!